174900.KQ
AbClon Inc.
KOE · Healthcare · Biotechnology · KR
KRW 19,610.00
−7.06%Year over year
Reported trailing growth
- Revenue
- +75.0%
- EBITDA
- —
- EBIT
- -16.6%
- EPS
- +1.3%
- Free cash flow
- +6.8%
- Operating cash flow
- +4.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +11.4%
- EBITDA
- -21.3%
- EBIT
- -14.7%
- Net income
- -9.8%
- EPS
- -2.5%
- Free cash flow
- +1.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026